Author:
Rajaei Taraneh,Farajifard Hamid,Rafatpanah Houshang,Bustani Reza,Valizadeh Narges,Rajaei Bahareh,Rezaee Seyed Abdolrahim
Publisher
Springer Science and Business Media LLC
Subject
Microbiology (medical),Immunology,General Medicine,Immunology and Allergy
Reference43 articles.
1. Bangham CRM, Araujo A, Yamano Y, Taylor GP (2015) HTLV-1-associated myelopathy/tropical spastic paraparesis. Nat Rev Dis Prim 1:15012. doi:
10.1038/nrdp.2015.12
2. Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F et al (2011) High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol 52:172–176. doi:
10.1016/j.jcv.2011.07.004
3. Boostani R, Vakili R, Hosseiny SS et al (2015) Triple therapy with prednisolone, pegylated interferon and sodium valproate improves clinical outcome and reduces human T-cell leukemia virus type 1 (HTLV-1) proviral load, tax and HBZ mRNA expression in patients with HTLV-1-associated myelopathy/tropical. Neurother 12:887–895. doi:
10.1007/s13311-015-0369-3
4. Yari A, Rezaee SA, Valizadeh N et al (2014) Evaluation of HTLV-1 activity in HAM/TSP patients using proviral load and Tax mRNA expression after In Vitro lymphocyte activation. Iran J BasicMed Sci 17:531–536
5. Bangham CR (2008) HTLV-1 infection: role of CTL efficiency. Blood 112:2176–2177. doi:
10.1182/blood-2008-06-163071
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献